News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG, Roche (RHHBY)’s Xolair Blunts Asthma Attacks in Children in U.S. Cities



3/17/2011 7:19:08 AM

Bloomberg -- Xolair, sold by Novartis AG (NOVN) and Roche Holding AG (ROG), improved treatment of asthma for inner-city children and young adults, according to a U.S.-funded study.

Read at Bloomberg
Read at News Release
Read at WebMD
Read at US News


comments powered by Disqus
Novartis AG
Roche
 
 
Asthma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES